Remarkably, main hub proteins in the CR group were VTN, C3, C4B, C9, and CFH that play a major role in the complementary pathway (Figure S5F), which has gained increased attention as a major contributor to cancer‐related coagulopathy [16]. This evidence concerns the gene C9 and blood coagulation disease.